Clsi E Coli Breakpoints 2024 E. + change of breakpoint for daptomycin and enterococcus spp. Extensive analysis of pk/pd, clinical outcomes, and current susceptibility profiles for enterobacterales and p.
Breakpoints are part of a system for categorising microorganisms as susceptible (s and i) and resistant (r) to agents approved for use in the treatment of infectious diseases. Clsi and cap 2024 webinar: